OBJECTIVE: We sought to examine the relation between meeting or exceeding the current minimum guideline for hemoglobin (11 g/dl) in dialysis patients and generic and disease-specific QOL scores at 1 year. METHODS: In 438 incident hemodialysis patients from a national prospective cohort study, we used regression models to predict QOL score (all scaled 0-100) at 1 year using 6-month values of hemoglobin, adjusting for potential confounders. RESULTS: Compared to values < 11 g/dl, hemoglobin > or = 11 g/dl at 6 months was associated with higher scores for the general domains of physical functioning, role physical, mental health, social functioning, and bodily pain at 1 year; cognitive function, diet restriction, and dialysis access dialysis-specific domain scores were also higher for these patients. Each 1 g/dl greater hemoglobin was also statistically significantly associated with higher QOL scores for most domains. In longitudinal analyses, most of the domains showed that, with each 1 g/dl increase in hemoglobin concentration from baseline to 6 months, QOL score increased significantly over the first year. CONCLUSIONS: Hemodialysis patients who attain higher hemoglobin concentration at 6 months, especially > or = 11 g/dl, have better QOL at 1 year, with regard to important physical, mental, social, and cognitive domains.
OBJECTIVE: We sought to examine the relation between meeting or exceeding the current minimum guideline for hemoglobin (11 g/dl) in dialysis patients and generic and disease-specific QOL scores at 1 year. METHODS: In 438 incident hemodialysis patients from a national prospective cohort study, we used regression models to predict QOL score (all scaled 0-100) at 1 year using 6-month values of hemoglobin, adjusting for potential confounders. RESULTS: Compared to values < 11 g/dl, hemoglobin > or = 11 g/dl at 6 months was associated with higher scores for the general domains of physical functioning, role physical, mental health, social functioning, and bodily pain at 1 year; cognitive function, diet restriction, and dialysis access dialysis-specific domain scores were also higher for these patients. Each 1 g/dl greater hemoglobin was also statistically significantly associated with higher QOL scores for most domains. In longitudinal analyses, most of the domains showed that, with each 1 g/dl increase in hemoglobin concentration from baseline to 6 months, QOL score increased significantly over the first year. CONCLUSIONS: Hemodialysis patients who attain higher hemoglobin concentration at 6 months, especially > or = 11 g/dl, have better QOL at 1 year, with regard to important physical, mental, social, and cognitive domains.
Authors: N V Athienites; D C Miskulin; G Fernandez; S Bunnapradist; G Simon; M Landa; C H Schmid; S Greenfield; A S Levey; K B Meyer Journal: Semin Dial Date: 2000 Sep-Oct Impact factor: 3.455
Authors: Dana C Miskulin; Klemens B Meyer; Nicolaos V Athienites; Alice A Martin; Norma Terrin; Jane V Marsh; Nancy E Fink; Josef Coresh; Neil R Powe; Mike J Klag; Andrew S Levey Journal: Am J Kidney Dis Date: 2002-02 Impact factor: 8.860
Authors: Isabel Vázquez; Fernando Valderrábano; Rosa Jofré; Joan Fort; Juan M López-Gómez; Fuensanta Moreno; Dámaso Sanz-Guajardo Journal: J Nephrol Date: 2003 Nov-Dec Impact factor: 3.902
Authors: Donna L Mapes; Antonio Alberto Lopes; Sudtida Satayathum; Keith P McCullough; David A Goodkin; Francesco Locatelli; Shunichi Fukuhara; Eric W Young; Kiyoshi Kurokawa; Akira Saito; Jürgen Bommer; Robert A Wolfe; Philip J Held; Friedrich K Port Journal: Kidney Int Date: 2003-07 Impact factor: 10.612
Authors: Aaron S Yarlas; Michelle K White; Min Yang; Renee N Saris-Baglama; Peter Galthen Bech; Torsten Christensen Journal: Qual Life Res Date: 2010-10-23 Impact factor: 4.147
Authors: F Yang; K Griva; T Lau; A Vathsala; E Lee; H J Ng; N Mooppil; M Foo; S P Newman; K S Chia; N Luo Journal: Qual Life Res Date: 2015-03-24 Impact factor: 4.147
Authors: Eduardo Lacson; Jianglin Xu; Shu-Fang Lin; Sandie Guerra Dean; J Michael Lazarus; Raymond M Hakim Journal: Clin J Am Soc Nephrol Date: 2009-12-17 Impact factor: 8.237
Authors: Steven M Brunelli; Katherine E Lynch; Elizabeth D Ankers; Marshall M Joffe; Wei Yang; Ravi I Thadhani; Harold I Feldman Journal: Clin J Am Soc Nephrol Date: 2008-10-15 Impact factor: 8.237
Authors: Murilo Guedes; Camila R Guetter; Lucas H O Erbano; Andre G Palone; Jarcy Zee; Bruce M Robinson; Ronald Pisoni; Thyago Proença de Moraes; Roberto Pecoits-Filho; Cristina P Baena Journal: BMC Nephrol Date: 2020-07-08 Impact factor: 2.388